Bio-FD&C Co Ltd banner
B

Bio-FD&C Co Ltd
KOSDAQ:251120

Watchlist Manager
Bio-FD&C Co Ltd
KOSDAQ:251120
Watchlist
Price: 15 490 KRW -2.46% Market Closed
Market Cap: ₩134.8B

Net Margin

37.7%
Current
Improving
by 4.9%
vs 3-y average of 32.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
37.7%
=
Net Income
₩7.1B
/
Revenue
₩18.8B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
37.7%
=
Net Income
₩7.1B
/
Revenue
₩18.8B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Bio-FD&C Co Ltd
KOSDAQ:251120
132.1B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
409.8B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
198.7B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
193.1B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
124.5B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
84.3B USD
Loading...
AU
CSL Ltd
ASX:CSL
72.6B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.1B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Higher than 96% of companies in Korea
Percentile
96th
Based on 2 632 companies
96th percentile
37.7%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Bio-FD&C Co Ltd
Glance View

Market Cap
134.8B KRW
Industry
Biotechnology

Bio-FD&C Co., Ltd. engages in the development of bio and health technologies. The company is headquartered in Incheon, Incheon and currently employs 61 full-time employees. The company went IPO on 2022-02-21. The firm is mainly engaged in the manufacture and sale of soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, acanthopanax koreanum adventitious root culture extract. The firm's products are mainly used as materials for cosmeceuticals, health functional foods and pharmaceuticals.

Intrinsic Value
15 851.4 KRW
Undervaluation 2%
Intrinsic Value
Price
B
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
37.7%
=
Net Income
₩7.1B
/
Revenue
₩18.8B
What is Bio-FD&C Co Ltd's current Net Margin?

The current Net Margin for Bio-FD&C Co Ltd is 37.7%, which is above its 3-year median of 32.8%.

How has Net Margin changed over time?

Over the last 3 years, Bio-FD&C Co Ltd’s Net Margin has increased from 23.7% to 37.7%. During this period, it reached a low of 23.7% on Aug 30, 2022 and a high of 37.7% on Oct 30, 2025.

Back to Top